General Management Approach to Dystonia

Therapeutics of Parkinson's Disease and Other Movement Disorders

Volumn , Issue , 2008, Pages 217-226

  Comella, Cynthia L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dystonia; Management; Non pharmacologic; Oral medication; Treatment guidelines

Indexed keywords

EID: 84870315070     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470713990.ch13     Document Type: Chapter

References (89)

1. Albanese, A., Barnes, M.P. et al. (2006) A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. European Journal of Neurology, 13 (5), 433-444.
2. Asmus, F. and Gasser, T. (2004) Inherited myoclonus-dystonia. Advances in Neurology, 94, 113-119.
3. Balash, Y. and Giladi, N. (2004) Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options. European Journal of Neurology, 11 (6), 361-370.
4. Bandmann, O., Marsden, C.D. et al. (1998a) Atypical presentations of dopa-responsive dystonia. Advances in Neurology, 78, 283-290.
5. Bandmann, O., Valente, E.M. et al. (1998b) Dopa-responsive dystonia: a clinical and molecular genetic study. Annals of Neurology, 44 (4), 649-656.
6. Bara-Jimenez, W., Shelton, P. et al. (2000a) Spatial discrimination is abnormal in focal hand dystonia. Neurology, 55 (12), 1869-1873.
7. Bara-Jimenez, W., Shelton, P. et al. (2000b) Sensory discrimination capabilities in patients with focal hand dystonia. Annals of Neurology, 47 (3), 377-380.
8. Barrett, R.E., Yahr, M.D. et al. (1970) Torsion dystonia and spasmodic torticollis-results of treatment with L-dopa. Neurology, 20 (11), 107-113.
9. Baur, B., Schenk, T. et al. (2006) Modifiedpen grip in the treatment of Writer's Cramp. Human Movement Science, 25 (4-5), 464-473.
10. Brans, J.W., Lindeboom, R. et al. (1996) Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial. Neurology, 46 (4), 1066-1072.
11. Burbaud, P., Guehl, D. et al. (1998) A pilot trial of clozapine in the treatment of cervical dystonia. Journal of Neurology, 245 (6-7), 329-331.
12. Burke, R.E. and Fahn, S. (1985) Serum trihexyphenidyl levels in the treatment of torsion dystonia. Neurology, 35 (7), 1066-1069.
13. Burke, R.E., Fahn, S. and Marsden, C.D. (1986) Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology, 33 (2), 160-164.
14. Byl, N.N. and McKenzie, A. (2000) Treatment effectiveness for patients with a history of repetitive hand use and focal hand dystonia: a planned, prospective follow-up study. Journal of Hand Therapy, 13 (4), 289-301.
15. Byl, N.N., Nagajaran, S. et al. (2003) Effect of sensory discrimination training on structure and function in patients with focal hand dystonia: a case series. Archives of Physical Medicine and Rehabilitation, 84 (10), 1505-1514.
16. Candia, V., Rosset-Llobet, J. et al. (2005) Changing the brain through therapy for musicians' hand dystonia. Annals of the New York Academy of Sciences, 1060, 335-342.
17. Candia, V., Schafer, T. et al. (2002) Sensory motor retuning: a behavioral treatment for focal hand dystonia of pianists and guitarists. Archives of Physical Medicine and Rehabilitation, 83 (10), 1342-1348.
18. Chen, R. (2000) Studies of human motor physiology with transcranial magnetic stimulation. Muscle Nerve Suppl, 9, S26-S32.
19. Coleman, M. (1970) Preliminary remarks on the L-dopa therapy of dystonia. Neurology, 20 (11), 114-121.
20. Davis, T.L., Charles, P.D. et al. (1995) Clonazepam-sensitive intermittent dystonic tremor. Southern Medical Journal, 88 (10), 1069-1071.
21. Diederich, N.J., Comella, C.L. et al. (1997) Sustained effect of high-dose intrathecal baclofen in primary generalized dystonia: a 2-year follow-up study. Movement Disorders, 12 (6), 1100-1102.
22. Dykstra, D.D., Mendez, A. et al. (2005) Treatment of cervical dystonia and focal hand dystonia by high cervical continuously infused intrathecal baclofen: a report of 2 cases. Archives of Physical Medicine and Rehabilitation, 86 (4), 830-833.
23. Fahn, S. (1983) High dosage anticholinergic therapy in dystonia. Neurology, 33 (10), 1255-1261.
24. Fletcher, N.A., Thompson, P.D. et al. (1993) Successful treatment of childhood onset symptomatic dystonia with levodopa. Journal of Neurology, Neurosurgery, and Psychiatry, 56 (8), 865-867.
25. Ford, B., Greene, P. et al. (1996) Use of intrathecal baclofen in the treatment of patients with dystonia. Archives of Neurology, 53 (12), 1241-1246.
26. Frucht, S., Fahn, S. et al. (1999) A geste antagoniste device to treat jaw-closing dystonia. Movement Disorders, 14 (5), 883-886.
27. Garg, B.P. (1982) Dystonia musculorum deformans: implications of therapeutic response to levodopa and carbamazepine. Archives of Neurology, 39 (6), 376-377.
28. Geller, M., Kaplan, B. et al. (1976) Treatment of dystonic symptoms with carbamazepine. Advances in Neurology, 14, 403-410.
29. Greene, P. (1992) Baclofen in the treatment of dystonia. Clinical Neuropharmacology, 15 (4), 276-288.
30. Greene, P., Shale, H. et al. (1988) Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia. Advances in Neurology, 50, 547-556.
31. Greene, P.E. and Fahn, S. (1992) Baclofen in the treatment of idiopathic dystonia in children. Movement Disorders, 7 (1), 48-52.
32. Hanagasi, H.A., Bilgic, B. et al. (2004) Clozapine treatment in oromandibular dystonia. Clinical Neuropharmacology, 27 (2), 84-86.
33. HSG (2006) Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology, 66 (3), 366-372.
34. Hughes, A.J., Lees, A.J. et al. (1991) Paroxysmal dystonic head tremor. Movement Disorders, 6 (1), 85-86.
35. Hurvitz, E.A., Ellenberg, M.R. et al. (1988) Orthotic technique for dystonia musculorum deformans. Archives of Physical Medicine and Rehabilitation, 69 (10), 892-894.
36. Jacome, D.E. (1988) Writing tremor myoclonus. European Neurology, 28 (3), 126-130.
37. Jaffe, M.S. and Nienstedt, L.J. (2001) Intrathecal baclofen for generalized dystonia: a case report. Archives of Physical Medicine and Rehabilitation, 82 (6), 853-855.
38. Jahanshahi, M. (2000) Factors that ameliorate or aggravate spasmodic torticollis. Journal of Neurology, Neurosurgery, and Psychiatry, 68 (2), 227-229.
39. Jankovic, J. (1982) Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Annals of Neurology, 11 (1), 41-47.
40. Jankovic, J. (2006) Treatment of dystonia. The Lancet Neurology, 5 (10), 864-872.
41. Jankovic, J. and Beach, J. (1997) Long-term effects of tetrabena-zine in hyperkinetic movement disorders. Neurology, 48 (2), 358-362.
42. Jankovic, J. and Ford, J. (1983) Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Annals of Neurology, 13 (4), 402-411.
43. Jankovic, J. and Orman, J. (1988) Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology, 38 (3), 391-394.
44. Karp, B.I., Goldstein, S.R. et al. (1999) An open trial of clozapine for dystonia. Movement Disorders, 14 (4), 652-657.
45. Kenney, C., Hunter, C. et al. (2006) Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Movement Disorders, 22 (2), 193-197.
46. Kenney, C. and Jankovic, J. (2006) Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Review of Neu-rotherapeutics, 6 (1), 7-17.
47. Kroin J.S., Ali, A., York, M. and Penn, R.D. (1993) The distribution of medication along the spinal canal after chronic intrathe-cal administration. Neurosurgery, 33 (2), 226-230.
48. Lang, A.E. (1988) Dopamine agonists and antagonists in the treatment of idiopathic dystonia. Advances in Neurology, 50, 561-570.
49. Lang, A.E. and Riley, D.E. (1992) Tizanidine in cranial dystonia. Clinical Neuropharmacology, 15 (2), 142-147.
50. Lang, A.E., Sheehy, M.P. et al. (1982) Anticholinergics in adult-onset focal dystonia. The Canadian Journal of Neurological Sciences, 9 (3), 313-319.
51. Lang, A.E., Sheehy, M.P. et al. (1983) Acute anticholinergic action in focal dystonia. Advances in Neurology, 37, 193-200.
52. Lucetti, C., Nuti, A. et al. (2000) Mexiletine in the treatment of torticollis and generalized dystonia. Clinical Neuropharmacol-ogy, 23 (4), 186-189.
53. Mandell, S. (1970) The treatment of dystonia with L-dopa and haloperidol. Neurology, 20 (11), 103-106.
54. Marsden, C.D., Marion, M.H. et al. (1984) The treatment of severe dystonia in children and adults. Journal of Neurology, Neuro-surgery, and Psychiatry, 47 (11), 1166-1173.
55. Meythaler, J.M., Guin-Renfroe, S. et al. (1999) Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. Archives of Physical Medicine and Rehabilitation, 80 (1), 13-19.
56. Mubaidin, A.F. (2000) Alcohol with xylocaine for treatment of eyelid dystonia. European Journal of Neurology, 7 (2), 213-215.
57. Muller, J., Wenning, G.K. et al. (2002) Riluzole therapy in cervical dystonia. Movement Disorders, 17 (1), 198-200.
58. Murase, N., Rothwell, J.C. et al. (2005) Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp. Brain, 128 (PT 1), 104-115.
59. Narayan, R.K., Loubser, P.G. et al. (1991) Intrathecal baclofen for intractable axial dystonia. Neurology, 41 (7), 1141-1142.
60. Nygaard, T.G., Trugman, J.M. et al. (1990) Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology, 40 (1), 66-69.
61. Ohara, S., Hayashi, R. et al. (1998) Mexiletine in the treatment of spasmodic torticollis. Movement Disorders, 13 (6), 934-940.
62. Ohara, S., Miki, J. et al. (1997) Treatment of spasmodic torticollis with mexiletine: a case report. Movement Disorders, 12 (3), 466-469.
63. Okun, M.S., Nadeau, S.E. et al. (2002) Immobilization dystonia. Journal of the Neurological Sciences, 201 (1-2), 79-83.
64. Paleacu, D., Giladi, N. et al. (2004) Tetrabenazine treatment in movement disorders. Clinical Neuropharmacology, 27 (5), 230-233.
65. Papapetropoulos, S. and Singer, C. (2006) Improvement of cervi-co-trunco-brachial segmental dystonia with topiramate. Journal of Neurology, 253 (4), 535-536.
66. Pesenti, A., Barbieri, S. et al. (2004) Limb immobilization for occupational dystonia: a possible alternative treatment for selected patients. Advances in Neurology, 94, 247-254.
67. Pohl, C., Happe, J. et al. (2002) Cooling improves the writing performance of patients with writer's cramp. Movement Disorders, 17 (6), 1341-1344.
68. Povlsen, U.J. and Pakkenberg, H. (1990) Effect of intravenous injection of biperiden and clonazepam in dystonia. Movement Disorders, 5 (1), 27-31.
69. Priori, A., Pesenti, A. et al. (2001) Limb immobilization for the treatment of focal occupational dystonia. Neurology, 57 (3), 405-409.
70. Ranawaya, R. and Lang, A. (1991) Usefulness of a writing device in writer's cramp. Neurology, 41 (7), 1136-1138.
71. Reeves, R.R. and Liberto, V. (2003) Treatment of essential bleph-arospasm with quetiapine. Movement Disorders, 18 (9), 1072-1073.
72. Santiago-Palma, J., Hord, E.D. et al. (2004) Respiratory distress after intrathecal baclofen withdrawal. Anesthesia and Analgesia, 99 (1), 227-229.
73. Schneider, S.A., Mohire, M.D. et al. (2006) Familial dopa-respon-sive cervical dystonia. Neurology, 66 (4), 599-601.
74. Shirzadi, A.A. and Ghaemi, S.N. (2006) Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome. Harvard Review of Psychiatry, 14 (3), 152-164.
75. Siebner, H.R., Tormos, J.M. et al. (1999) Low-frequency repetitive transcranial magnetic stimulation of the motor cortex in writer's cramp. Neurology, 52 (3), 529-537.
76. Tas, N., Karatas, G.K. et al. (2001) Hand orthosis as a writing aid in writer's cramp. Movement Disorders, 16 (6), 1185-1189.
77. Taub, E., Uswatte, G. et al. (2006) The learned nonuse phenomenon: implications for rehabilitation. Eura Medicophys, 42 (3), 241-256.
78. Taub, E., Uswatte, G. et al. (2003) Improved motor recovery after stroke and massive cortical reorganization following Constraint-Induced Movement therapy. Physical Medicine and Rehabilitation Clinics of North America, 14 (1 Suppl), S77-S91 ix.
79. Taub, E., Uswatte, G. et al. (1999) Constraint-Induced Movement Therapy: a new family of techniques with broad application to physical rehabilitation-a clinical review. Journal of Rehabilitation Research & Development, 36 (3), 237-251.
80. Thiel, A., Dressler, D. et al. (1994) Clozapine treatment of spasmodic torticollis. Neurology, 44 (5), 957-958.
81. Tinazzi, M., Zarattini, S. et al. (2005) Long-lasting modulation of human motor cortex following prolonged transcutaneous electrical nerve stimulation (TENS) of forearm muscles: evidence of reciprocal inhibition and facilitation. Experimental Brain Research, 161 (4), 457-464.
82. Tinazzi, M., Zarattini, S. et al. (2006) Effects of transcutaneous electrical nerve stimulation on motor cortex excitability in writer's cramp: neurophysiological and clinical correlations. Movement Disorders, 21 (11), 1908-1913.
83. Trugman, J.M., Leadbetter, R. et al. (1994) Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis. Movement Disorders, 9 (4), 441-446.
84. Vender, J.R., Hester, S. et al. (2006) Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. Journal of Neurosurgery, 104 (1 Suppl), 9-15.
85. Walker, R.H., Danisi, F.O. et al. (2000) Intrathecal baclofen for dystonia: benefits and complications during six years ofexperi-ence. Movement Disorders, 15 (6), 1242-1247.
86. Yoshida, K., Kaji, R. et al. (2002) Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct patho-physiology. International Journal of Oral and Maxillofacial Surgery, 31 (5), 499-505.
87. Zeuner, K.E., Bara-Jimenez, W. et al. (2002) Sensory training for patients with focal hand dystonia. Annals of Neurology, 51 (5), 593-598.
88. Zeuner, K.E. and Hallett, M. (2003) Sensory training as treatment for focal hand dystonia: a 1-year follow-up. Movement Disorders, 18 (9), 1044-1047.
89. Zeuner, K.E., Shill, H.A. et al. (2005) Motor training as treatment in focal hand dystonia. Movement Disorders, 20 (3), 335-341.